New uses of thalidomide
Medical Letter on Drugs and Therapeutics 38(968): 15-16
1996
ISSN/ISBN: 0025-732X PMID: 8592478 Document Number: 458806
Investigational drug status has been granted to thalidomide in the US for clinical trials in erythema nodosum leprosum, aphthous ulcers in patients with and without HIV (human immunodeficiency virus) infection, Behcet's disease, chronic graft versus host disease, inflammatory dermatoses and AIDS (acquired immune deficiency syndrome) wasting. The immunomodulator has several serious side effects, the most common being teratogenicity. The drug is available from Celgene, Andrulis, and the FDA.
Document emailed within 1 workday
